Mark L. Baum - Jan 2, 2023 Form 4 Insider Report for HARROW HEALTH, INC. (HROW)

Signature
/s/ Mark L. Baum
Stock symbol
HROW
Transactions as of
Jan 2, 2023
Transactions value $
-$519,242
Form type
4
Date filed
1/3/2023, 08:52 PM
Previous filing
Dec 23, 2022
Next filing
Apr 4, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HROW Common Stock Options Exercise +88K +6.14% 1.52M Jan 2, 2023 Direct F1
transaction HROW Common Stock Tax liability -$519K -35.2K -2.31% $14.76 1.48M Jan 2, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HROW Restricted Stock Unit Options Exercise $0 -88K -100% $0.00* 0 Jan 2, 2023 Common Stock 88K $0.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The listed Acquired (as described in the table above) 88,000 shares of Harrow Health, Inc. ("Harrow") common stock represent restricted stock units ("RSUs") granted to Mr. Baum under the Issuer's 2017 Stock Incentive and Awards Plan on January 2, 2020. The RSUs, which vested in full on January 2, 2023, the third-year anniversary of the grant of the same, settled as one share of common stock for each RSU. The listed Disposed (as described in the table above) 35,179 shares of Harrow common stock were not sold by Mr. Baum in any transaction; rather, they were shares of Harrow common stock withheld, by the Company, from the same aforementioned 88,000 RSU share issuance for payroll tax purposes only.